May 03, 2019

Talks with Docs: Brad Cairns, PhD

Brad Cairns, PhD, is not only a scientist—he also loves mountain biking and jazz music. Learn more about his many passions, including his work at Huntsman Cancer Institute, in this episode of Talks with Docs.

Apr 08, 2019

Cancer Registrars: Capturing the Picture of Cancer

Do you ever wonder how cancer statistics are collected? How doctors determine what cancer treatments are the most effective? Or how public health officials learn where clusters of cancer diagnoses are located? The work that we do as cancer registrars provides answers to these questions.

Apr 01, 2019

Huntsman Cancer Institute Contributes to Colorectal Cancer Research Studies

Huntsman Cancer Institute contributed to two research studies involving how microbes living in and on our body play a role in the development of colorectal cancer.

Mar 28, 2019

Letter of Hope from the Ulrich Group

We can only imagine how hard it must be for patients, along with their caregivers and loved ones, to hear they have cancer. Our shared purpose is to make it so no one has to experience these difficult emotions in the future by researching how to prevent cancer before it happens.

Mar 22, 2019

Huntsman Cancer Institute Researchers Appointed to National Scientific Leadership Roles

Huntsman Cancer Institute's CEO, Mary Beckerle, PhD, and Senior Director of Pre-Clinical Translation, Martin McMahon, PhD, have been appointed to prominent national advisory boards within the National Institutes of Health to provide expert advice on national cancer research initiatives.

Mar 01, 2019

Together We Advance Research

Cornelia Ulrich, PhD, executive director of the Comprehensive Cancer Center at HCI, explains how HCI's community of highly motivated and dedicated researchers, staff, and trainees is focused on one thing: eradicating suffering caused by cancer.

Mar 01, 2019

Exercise for Improved Outcomes

The Precision Exercise Prescription study is a unique collaboration between medical doctors, researchers, physical therapists, and patients. The study looks at how an exercise program tailored for each patient can improve long-term outcomes after lung cancer surgery.

Mar 01, 2019

Pancreas Discovery Moves from Lab to Clinic

In less than three years, HCI researchers have taken an idea from concept to lab to clinical evaluation. Conan Kinsey, MD, PhD, and Martin McMahon, PhD, combined two drugs that had not been used in combination before to treat pancreatic tumors. The results were promising and they were able to move from the lab to clinical trial quickly. A clinical trial to test the safety and effect of this drug combination in pancreatic cancer is now underway at HCI and planned at other sites around the United States.